Harmine suppresses breast cancer cell migration and invasion by regulating TAZ-mediated epithelial-mesenchymal transition.

He, Jinrong; Chen, Shanshan; Yu, Tong; Chen, Weiqun; Huang, Jin; Peng, Caixia; Ding, Yu

He, Jinrong; Chen, Shanshan; Yu, Tong; Chen, Weiqun; Huang, Jin; Peng, Caixia; Ding, Yu.

Afiliación

He J; Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China.
Chen S; Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China.
Yu T; Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China.
Chen W; Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China.
Huang J; Department of Traditional Chinese Medicine, Humanwell Healthcare (Group) Co., Ltd. Wuhan 430075, Hubei, China.
Peng C; Key Laboratory for Molecular Diagnosis of Hubei Province Hubei, China.
Ding Y; Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430014, Hubei, China.

Am J Cancer Res ; 12(6): 2612-2626, 2022.

Article en En | MEDLINE | ID: mdl-35812064

Palabras clave

Harmine; TAZ; breast cancer cell; epithelial-mesenchymal transition; metastasis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: China